Toxin tied to deadly staph pneumonia under the microscope
NCT ID NCT02798497
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study looked at 234 patients with severe staph pneumonia to see if a toxin called PVL makes the disease worse. Researchers compared survival rates between patients infected with PVL-producing bacteria and those without. They also collected blood samples to explore whether genetics play a role in how sick people get.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict which patients with staph pneumonia are at highest risk and guide treatment decisions.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not change current medical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAPHYLOCOCCUS AUREUS PNEUMONIAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre National de Références des Staphylocoques Centre de Biologie et Pathologie Est 59 bd Pinel
Bron, 69677, France